Position in DYAI
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$37,570
+$3,340 QoQ
Shares Held
41,745
0.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DYAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $6,120,036 across 7 Biotechnology names. DYAI ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
94,250 | $4,341,155 | |
| 2 | ARDX |
Ardelyx, Inc.
|
226,400 | $1,154,640 | |
| 3 | CRMD |
CorMedix Inc.
|
54,000 | $423,900 | |
| 4 | GALT |
Galectin Therapeutics Inc
|
30,000 | $139,200 | |
| 5 | DYAI |
Dyadic International Inc
This page
|
41,745 | $37,570 | |
| 6 | CRBU |
Caribou Biosciences, Inc.
|
10,000 | $17,600 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
13,992 | $5,971 |
All Filings in DYAI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,570 | 41,745 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $34,230 | 41,745 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $39,240 | 41,745 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $49,259 | 41,745 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $46,549 | 47,020 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $63,477 | 47,020 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $82,285 | 47,020 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $48,900 | 47,020 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $69,589 | 47,020 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $78,523 | 47,020 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $75,702 | 47,020 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $94,329 | 49,130 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $94,820 | 49,130 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $87,451 | 49,130 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $60,429 | 49,130 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $97,868 | 51,240 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $156,282 | 51,240 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $154,232 | 51,240 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $241,142 | 53,350 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $296,626 | 53,350 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $191,526 | 53,350 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $292,891 | 53,350 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $287,023 | 53,350 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $403,859 | 53,350 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $462,011 | 53,350 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $277,420 | 53,350 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||